Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. – FDA Inspection, Mar 14, 2025

Record Details

This FDA Inspection record concerns Shandong Chenghui Shuangda Pharmaceutical Co., Ltd., with an inspection on March 14, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.
Inspection Date: March 14, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Robert J. Ham (FDA Associated Person)

View Company Profile

ID · 3ba07fa9-6baa-496d-a87e-3cdee78f1d2d

Inspection Facts

Inspection number: 1269490
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.

FDA Inspection

Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.March 14, 2025